Labopharm’s Ryzolt pain reliever approved by Food and Drug Administration (Canadian Business)

MONTREAL - Investors in Labopharm Inc. (TSX:DDS) held a New Year's Eve celebration after the U.S. Food and Drug Administration approved Ryzolt,

[News Source]